Final Program

MONDAY • MAY 16 141
Medicine. The symposium will provide the perspective of leaders and future
leaders within the field of international respiratory health, identify common
obstacles, and provide strategies for career development for early and mid-level
career scientists, physicians and other professionals within and outside the United
States.
Chairing: Y.N. Mageto, MD, MPH, Burlington, VT
G. Matute-Bello, MD, Seattle, WA
9:00 Collaborative Team Field Science: Skills and Methodology
Required for Success
A.S. Buist, MD, Portland, OR
9:20 Translational Research in Low Resource Settings: Skills and
Methodology Required for Success
T.E. West, MD, MPH, Seattle, WA
9:40 Education and Training Development in Low and Middle
Income Countries: The Nuts and Bolts
E.J. Carter, MD, Providence, RI
10:00 Capacity Building in Developing Countries: Challenges and
Opportunities on the Ground
D. Obaseki, MD, MPH, Ile-Ife, Nigeria
10:20 Epidemiology and Implementation Science:Targeting Chronic
Respiratory Diseases in Developing Countries
C.M. Patino, MD, PhD, Los Angeles, CA
10:40 Challenges and Opportunities on the Ground: Ethics,
Language, and Giving Back
S. Gordon, MA, MD, DTM&H, Blantyre, Malawi
B13
There will be a 5-minute discussion after each talk.
BASIC • CLINICAL
ATS PRESIDENT’S SYMPOSIUM
CME Credits Available: 2.0
APPLIED PHYSIOLOGY IS ALIVE AND WELL
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Target Audience
Students, clinicians, scientists and educators.
Room 2016/2018 (West Building, Level 2)
Objectives
At the conclusion of this session, the participant will be able to:
• define the inflammatory reflex;
• apply the concept of driving pressure at the bedside;
• define loop gain and understand its therapeutic importance.
Although some people have suggested that physiology is dead, this session will
present the case that physiology is still alive and well. Many of the advances in
patient care which have occurred in recent years have been a result of
physiology. Even though molecular and cellular biology have made major
advances, the importance of function remains critical. Similarly with advances in
genetics and genomics in recent years, the importance of these genes is
assessed by functional assessments. Terms such as deep phenotyping reflect
acknowledgement that physiological function remains crucial.
Chairing: A. Malhotra, MD, La Jolla, CA
T.S. Simonson, PhD, La Jolla, CA
9:00 Respiration Mechanics: Saving Lives for Nearly a Century
J.M. Drazen, MD, Boston, MA
9:10 Applied Physiology in Sleep Apnea and Control of Breathing
M.K. Younes, MD, PhD, Winnipeg, Canada
9:35 Unjamming and Cell Shape in the Asthmatic Airway Epithelium
J.J. Fredberg, PhD, Boston, MA
10:00 From Sepsis Mechanisms to the Origin of Bioelectronic
Medicines
K.J. Tracey, MD, Manhasset, NY
10:25 Assessing Regional Lung Strain and Perfusion at the Bedside:
The Future Is Now
M.B.P. Amato, MD, PhD, Sao Paulo, Brazil
10:50 Young Investigators Presentations
B14
LATE BREAKING MINI SYMPOSIUM
HIGH IMPACT LATE-BREAKING CLINICAL TRIALS
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 3010/3012 (West Building, Level 3)
Chairing: R. Kalhan, MD, MS, Chicago, IL
R.K. Albert, MD, Aurora, CO
M.T. Naughton, MBBS, MD, Prahran, Australia
Oral Presentations
9:00 Use of a Plasma Proteomic Biomarker in Addition to Clinician
Pretest Probability in Pulmonary Nodules with Intermediate
Risk of Malignancy Improves Nodule Risk Assessment/N.T.
Tanner, G.A. Silvestri, Charleston, SC, p.A2862
9:15 Surgical and Large Bore Procedures in Malignant Pleural
Mesothelioma and Radiotherapy Trial (SMART Trial) - An RCT
Evaluating Whether Prophylactic Radiotherapy Reduces the
Incidence of Procedure Tract Metastases/N.A. Maskell, A.O.
Clive, Bristol, United Kingdom, p.A2863
9:30 Lung Injury Prevention Study with Aspirin (LIPS-A): A
Multicenter Randomized Clinical Trial/D.J. Kor, R.E. Carter, P.K.
Park, E. Festic, V. Banner-Goodspeed, R.F. Hinds, D.S. Talmor, O.
Gajic, M.N. Gong, Rochester, MN, p.A2864
9:45 Results of a Randomized Controlled Trial Testing if a Bedside
Consult that Coordinates Outpatient Services and Adds
Automated Follow-Up Helps Hospitalized Smokers Quit/R.A.
Mularski, L.A. Waiwaiole, M.C. Leo, M.C. Francisco, K.
Funkhouser, J.L. Fellows, Portland, OR, p.A2865
10:00 Profound Antitussive Response to P2X3 Blockade with AF-219
Permits Correlation of Objective Measure of Cough with
Improvement in Patient Reported Outcomes/J.A. Smith, M. Kitt,
M. Sher, P. Butera, A.P. Ford, Manchester, United Kingdom, p.A2866
MONDAY MORNING
ATS 2016 • San Francisco